Hypomethylating Agents in Combination With Histone Deacetylase Inhibitors in Higher Risk Myelodysplastic Syndromes: Is There a Light at the End of the Tunnel?
Cancer - United States
doi 10.1002/cncr.30532
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2017
Authors
Publisher
Wiley